Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
clinical trials
fda
life sciences
national blog main
amgen
eli lilly
europe blog main
national
national top stories
san francisco blog main
san francisco top stories
abaloparatide
abbvie
allergan
avapritinib
bempedoic acid
biohaven
blueprint medicines
boston
boston blog main
boston top stories
cgpr
cholesterol
corticosteroids
cstone pharmaceuticals
deals
detroit
detroit blog main
detroit top stories
esperion therapeutics
europe top stories
european commission
european medicines agency
ezetimibe
fisogatinib
flatiron health
fluoroquinolones
genentech
hepatocellular carcinoma
What
wins
4
×
drug
fda
medicines
nod
approval
approved
marketing
pill
regulatory
adults
allergan
amgen
amgen’s
blueprint
cancer
candidate
carries
cholesterol
class
combo
currently
developed
esperion
esperion’s
europe
european
heart
levels
lowering
medicine
migraine
monday
muscle
new
osteoporosis
pact
pairs
raise
ret
Language
unset
Current search:
wins
×
biotech
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning